ARS Pharmaceuticals, Inc. SPRY Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by ARS Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The official record: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about ARS Pharmaceuticals, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ARS Pharmaceuticals, Inc.'s short-term investments?
- ARS Pharmaceuticals, Inc. (SPRY) reported short-term investments of $176.65M in Q1 2026.
- How has ARS Pharmaceuticals, Inc.'s short-term investments changed year-over-year?
- ARS Pharmaceuticals, Inc.'s short-term investments decreased by 25.1% year-over-year, from $235.86M to $176.65M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.